Three 62 Ten Research Group has brought a new, state-of-the-art research and development lab online at its New Britain, Connecticut facility — a significant expansion of our capacity to develop Ayurvedic-based nutraceuticals from concept to finished product.
More room to develop
The new lab is the centerpiece of our 2026 move to New Britain, uniting research and manufacturing under one roof. It expands our ability to authenticate botanicals, produce standardized extracts, and prototype formulations — the early, decisive stages where a product’s quality is set.
What it means for partners
For the brands we work with, the expanded lab means faster development cycles and more headroom for custom and clinically supported projects. Because development now sits alongside production, a formulation can move from the bench to a pilot batch without leaving the building — preserving the traceability and consistency that our vertically integrated model is built on.
The same standard, more capacity
The facility continues to operate under GMP-compliant procedures, with Certificates of Analysis (COAs) and third-party testing available for every batch. The investment doesn’t change our standards — it lets us apply them to more projects, at greater scale.
Interested in developing or manufacturing a product with us? Start a project or get in touch.